 David Patrick Sparling
| Title | Assistant Professor |
|---|
| Institution | University of Oklahoma Health Sciences Center |
|---|
| Department | Dept of Pediatrics |
|---|
| Address | 1200 Children's Ave
Oklahoma City OK 73104-4600
|
|---|
| Phone | 405/271-8001 |
|---|
| vCard | Download vCard |
|---|
|
|
|
 Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
-
Sparling DP, Fabian K, Harik L, Jobanputra V, Anyane-Yeboa K, Oberfield SE, Fennoy I. Congenital hypothyroidism and thyroid dyshormonogenesis: a case report of siblings with a newly identified mutation in thyroperoxidase. J Pediatr Endocrinol Metab. 2016 May 01; 29(5):627-31. PMID: 26894573; PMCID: PMC4853235.
-
Kim K, Qiang L, Hayden MS, Sparling DP, Purcell NH, Pajvani UB. mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2. Nat Commun. 2016 Jan 08; 7:10255. PMID: 26743335; PMCID: PMC4729872.
-
Sparling DP, Yu J, Kim K, Zhu C, Brachs S, Birkenfeld AL, Pajvani UB. Adipocyte-specific blockade of gamma-secretase, but not inhibition of Notch activity, reduces adipose insulin sensitivity. Mol Metab. 2016 Feb; 5(2):113-21. PMID: 26909319; PMCID: PMC4735659.
-
Sparling DP, Griesel BA, Weems J, Olson AL. GLUT4 enhancer factor (GEF) interacts with MEF2A and HDAC5 to regulate the GLUT4 promoter in adipocytes. J Biol Chem. 2008 Mar 21; 283(12):7429-37. PMID: 18216015; PMCID: PMC2276327.
-
Sparling DP, Griesel BA, Olson AL. Hyperphosphorylation of MEF2A in primary adipocytes correlates with downregulation of human GLUT4 gene promoter activity. Am J Physiol Endocrinol Metab. 2007 Apr; 292(4):E1149-56. PMID: 17164432.
-
McGee SL, Sparling D, Olson AL, Hargreaves M. Exercise increases MEF2- and GEF DNA-binding activity in human skeletal muscle. FASEB J. 2006 Feb; 20(2):348-9. PMID: 16368714.
-
Holmes BF, Sparling DP, Olson AL, Winder WW, Dohm GL. Regulation of muscle GLUT4 enhancer factor and myocyte enhancer factor 2 by AMP-activated protein kinase. Am J Physiol Endocrinol Metab. 2005 Dec; 289(6):E1071-6. PMID: 16105857.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
| Year | Publications |
|---|
| 2005 | 2 | | 2006 | 1 | | 2008 | 1 | | 2015 | 1 | | 2016 | 2 |
To return to the timeline, click here.
|
Sparling's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|